User profiles for Catherine M. Biggs

Catherine Biggs

Clinical Assistant Professor, UBC
Verified email at bcchr.ca
Cited by 2903

Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths

…, SM Holland, CM Biggs, M Moncada-Vélez… - Science …, 2021 - science.org
Circulating autoantibodies (auto-Abs) neutralizing high concentrations (10 ng/ml; in plasma
diluted 1:10) of IFN-α and/or IFN-ω are found in about 10% of patients with critical COVID-19 …

The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

…, CM Biggs, M Moncada-Vélez… - Proceedings of the …, 2022 - National Acad Sciences
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection fatality rate (IFR)
doubles with every 5 y of age from childhood onward. Circulating autoantibodies neutralizing …

[HTML][HTML] SARS-CoV-2–related MIS-C: A key to the viral and genetic causes of Kawasaki disease?

…, P Brodin, A Cobat, CM Biggs… - Journal of Experimental …, 2021 - rupress.org
Multisystem inflammatory syndrome in children (MIS-C) emerged in April 2020 in communities
with high COVID-19 rates. This new condition is heterogenous but resembles Kawasaki …

Weathering the COVID-19 storm: lessons from hematologic cytokine syndromes

JT England, A Abdulla, CM Biggs, AYY Lee, KA Hay… - Blood Reviews, 2021 - Elsevier
A subset of patients with severe COVID-19 develop profound inflammation and multi-organ
dysfunction consistent with a “Cytokine Storm Syndrome” (CSS). In this review we compare …

Practical guidance for the evaluation and management of drug hypersensitivity: specific drugs

AD Broyles, A Banerji, S Barmettler, CM Biggs… - The Journal of Allergy …, 2020 - Elsevier
Allergists and clinical immunologists around the world are increasingly faced with the task
of addressing drug allergy and hypersensitivity due to the increase in drug reactions. …

Human germline heterozygous gain-of-function STAT6 variants cause severe allergic disease

…, D Bullens, K Sauer, T Claeys, CM Biggs… - Journal of Experimental …, 2023 - rupress.org
STAT6 (signal transducer and activator of transcription 6) is a transcription factor that plays
a central role in the pathophysiology of allergic inflammation. We have identified 16 patients …

DOCK8 deficiency: insights into pathophysiology, clinical features and management

CM Biggs, S Keles, TA Chatila - Clinical Immunology, 2017 - Elsevier
Dedicator of cytokinesis 8 (DOCK8) deficiency is a combined immunodeficiency that
exemplifies the broad clinical features of primary immunodeficiencies (PIDs), extending beyond …

Calm in the midst of cytokine storm: a collaborative approach to the diagnosis and treatment of hemophagocytic lymphohistiocytosis and macrophage activation …

…, EH Baris, LA Benson, CM Biggs, M Gorman… - Pediatric …, 2019 - Springer
Background Hemophagocytic lymphohistiocytosis (HLH) and macrophage activation syndrome
(MAS) were historically thought to be distinct entities, often managed in isolation. In fact, …

Innate immune control of EBV-infected B cells by invariant natural killer T cells

…, LL Allan, DJ Zheng, JC Nie, CM Biggs… - Blood, The Journal …, 2013 - ashpublications.org
Individuals with X-linked lymphoproliferative disease lack invariant natural killer T (iNKT)
cells and are exquisitely susceptible to Epstein-Barr virus (EBV) infection. To determine …

[HTML][HTML] Humans with inherited MyD88 and IRAK-4 deficiencies are predisposed to hypoxemic COVID-19 pneumonia

…, J Pachlopnik Schmid, CM Biggs… - Journal of Experimental …, 2023 - rupress.org
Disclosures: C. Flores reported grants from Instituto de Salud Carlos III, Spanish Ministry of
Science and Innovation, and Cabildo Insular de Tenerife outside the submitted work. J. …